Le Lézard
Classified in: Health, Business
Subjects: SVY, WOM, DEI

Women in the Workforce Face Significant Challenges Due to Menopause, Rank Their 50s as Most Challenging Decade at Work, Yet Receive Minimal Support, New Survey Reveals


Carrot Fertility's Menopause in the Workplace survey shows 79% of women cite working during menopause to be challenging; only 8% report feeling very prepared and informed for their overall menopause experience

MENLO PARK, Calif., Sept. 22, 2022 /PRNewswire/ -- Women in the workforce face significant challenges due to menopause, but they receive minimal support from employers, according to a new Menopause in the Workplace survey from Carrot Fertility. As the leading global fertility healthcare and family-forming benefits provider for employers and health plans, the company commissioned the survey ahead of Menopause Awareness Month to understand the effects of menopause on careers, identify resources available to menopausal women, and bring more awareness to menopause to further destigmatize it in the workplace. An estimated 1.1 billion women worldwide will have experienced menopause by 2025, with millions more going through perimenopause.

Women worry about menopause stigma at work 

Of the 1,000 people experiencing perimenopause or menopause across the U.S. who were surveyed, the vast majority of respondents (79%) describe working during menopause as challenging, more than other common life stages, including starting a new job (75% describe as challenging), starting a family (70%), or getting a promotion (62%). Relatedly, when asked what age decade is the most challenging for being in the workplace, respondents ranked their 50s as number one, well ahead of second-ranked 20s. 

Most women reported the need to take time off or faced other serious challenges in the workplace during menopause and perimenopause. A majority (54%) have encountered at least one menopause-driven work challenge, including loss of work time and job security concerns. Among the nearly 40% of respondents who took time off due to perimenopause or menopause symptoms, 71% lost more than 40 hours (one full week) of work time, and 30% reported losing more than a month of work time altogether. Of those who took time off, 59% felt they needed to conceal the reason for the time away.

Other workplace challenges tied to menopause reported by respondents include: perceived losses to credibility in the workplace, worries over job loss due to menopause stigma, and lost work friendships.

"We've made tremendous progress around the ability to understand and address the fertility challenges impacting younger individuals in their work life, but we are woefully behind when it comes to supporting employees with their fertility healthcare needs as they age," said Tammy Sun, Founder and CEO, Carrot Fertility. "The findings of this report spotlight the real challenges menopausal women in the workplace struggle with, including lost productivity and concerns over job security. The survey also validates the need for employers and business leaders to provide age-inclusive fertility benefits for employees."

High employee support for employer-provided age-inclusive fertility benefits

Most women surveyed were unfamiliar with workplace menopause benefits but highly supportive of the concept. In fact, 82% of respondents see such benefits as valuable. This is on par with the importance of other major employer offerings, such as continuing education.

When asked what type of menopause benefits they deem valuable, a large majority of respondents cited fundamental benefits, such as medical care and support (88%), counseling and therapy (79%), and support groups (69%), as well as other offerings like menopause mentoring (66%), and office menopause rooms to manage their symptoms (58%). 

Despite employee support for benefits, employers currently offer few resources

While there is high support for employer-provided menopause benefits from people experiencing menopause and perimenopause, such offerings are rare and typically limited to flexible scheduling. Only 8% say their employer has offered significant support for menopause, compared to 59% who report no support at all. Among the 21% whose employers have offered significant or minor support, flexible scheduling is the most common (40%). 

According to the survey, if employers opted to offer menopause benefits, they would gain significant advantages, including employee retention. Of those menopausal women surveyed, 70% have considered at least one major employment-based change due to menopause, including 47% who have considered looking for remote or hybrid work, and nearly 1 in 5 (19%) who considered changing jobs for better menopause support. 

Other advantages for employers who offer benefits are increased job satisfaction and productivity. Among the respondents, 92% have at least one reason for believing menopause benefits should be provided by employers, such as employee retention and workplace fairness. Specifically, 62% say it would increase productivity, and 61% say it would improve job satisfaction. 

Few women feel prepared for menopause

Few respondents feel prepared for menopause: 65% describe their experience as difficult; only 8% report feeling very prepared and informed for the overall experience of menopause; and 47% say they were either not prepared or completely unprepared. Additionally, 59% of respondents shared that they were more prepared for childbirth than for menopause. 

Despite the lack of preparedness, many women shared that they've experienced both physical and emotional symptoms during menopause. Hot flashes (78%) are the most commonly reported physical symptom, followed closely by trouble sleeping (77%), fatigue (75%), night sweats (74%), and weight gain or slower metabolism (71%). Mood changes (68%) and anxiety (62%) are the most commonly reported emotional and mental health symptoms.

Discussing menopause at work is perceived as taboo; also affects personal and professional relationships

Additional findings of Carrot's Menopause in the Workplace survey spotlight the perception that discussing menopause at work is taboo, and the significant impact menopause has on respondents' personal and professional relationships.

The majority of people surveyed shared that they're uncomfortable discussing menopause at work: 77% of respondents noted feeling uncomfortable talking with executives about menopause, 63% feel uncomfortable talking with human resources, and 58% with their immediate supervisor. 

Most respondents (91%) have sought support for menopause from at least one major source, among which the most commonly reported is a doctor/physician (56%), followed by online searches and other forums (50%). Only 28% of respondents noted turning to their partner or spouse for support. 

Seventy-three percent say menopause has negatively impacted at least one category of interpersonal relationships, with romantic life being the most common (58%) and work-life relationships negatively impacted for 30% of respondents. 

"The dramatic hormonal changes stemming from menopause can result in symptoms that negatively impact people physically, mentally, and emotionally, in both their personal and professional lives, as confirmed by this survey," said Dr. Asima Ahmad, MD, MPH, Co-founder and Chief Medical Officer, Carrot Fertility. "What's also crystal clear from this survey is the diversity of support and benefits women in the workplace deem critical to their productivity, ranging from medical care to counseling and emotional support groups. We hope employers are taking note."

Earlier this year, Carrot pioneered a new line of clinically-validated, age-inclusive fertility benefits for employees going through every stage of menopause and low testosterone. Carrot customers now have the option to add comprehensive support for menopause and low testosterone as part of their fertility benefits package. For Carrot members, that means they have improved access to providers through a specialized network, clinically supervised education, intimate group support, and more. Members can opt into a personalized Carrot Plan, receive telehealth access to specialized experts, participate in expert-led group sessions, access Carrot-vetted providers that support menopause and low testosterone, and access additional resources.

Methodology

Carrot commissioned this scientific random sample of 1,000 women currently employed for wages, between the ages 40 to 55, who have all experienced menopause or perimenopause and are employed in the U.S. workforce. The survey was fielded between September 2 and September 4, 2022, and has a margin of error of 3.1% with 95% confidence. 

About Carrot Fertility

Carrot Fertility is the leading global fertility healthcare and family-forming benefits provider for employers and health plans. Companies use Carrot to customize an inclusive fertility benefit that provides employees financial, medical, and emotional support as they pursue parenthood and fertility care, reducing healthcare costs and resulting in better clinical outcomes. Carrot's clinically managed program includes fertility preservation like egg and sperm freezing, IVF, donor and gestational carrier services, adoption, pregnancy, menopause, and low testosterone support; Carrot Rx®, a premium pharmacy experience at significant savings; and the Carrot Card®, a flexible pre-funded card employees can use to pay for their care. Learn more at www.carrotfertility.com.

SOURCE Carrot Fertility


These press releases may also interest you

at 14:08
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
The Atrium at Cardinal Drive, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the second straight year. In U.S. News & World Report's third...

at 14:04
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy...

at 14:04
Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and...

at 14:00
Help at Home, the leading national provider of innovative, high-quality, home care services, today announced that it is encouraged by the Administration's continued recognition of the value of the home care industry and its critical role in support...

at 13:46
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for VETIGEL® to be sold through several leading regional distributors of...



News published on and distributed by: